Drugs / TG-C
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06144970 Comparator | Jan 2027 → Jul 2028 expected | intervertebral disk degenerative disorder | Kolon TissueGene, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TG-C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06144970 ↗ |
| Modality | Cell therapy | “combined TG-C cells” NCT06144970 ↗ |